BWL
PRAX icon

Bogart Wealth LLC’s Praxis Precision Medicines PRAX Stock Holding History

Bogart Wealth LLC’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$670 Buy
2
+1
+100% +$317 ﹤0.01% 1707
2026
Q1 		$322 Buy
+1
New +$309 ﹤0.01% 1665

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Bogart Wealth LLC's PRAX Position: Q2 2026 in Review

Bogart Wealth LLC increased its Praxis Precision Medicines (PRAX) stake by 100% in Q2 2026, buying an estimated $317 and bringing the position to 2 shares worth $670. The position accounts for ﹤0.01% of the portfolio, ranked #1707.

Bogart Wealth LLC first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Bogart Wealth LLC held 2 shares of Praxis Precision Medicines worth $670 as of Q2 2026.
  • Bogart Wealth LLC bought 1 Praxis Precision Medicines share in Q2 2026, an estimated $317.
  • Praxis Precision Medicines made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1707 holding.
  • Bogart Wealth LLC first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.